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Abstract 
Age-related macular degeneration (ARMD) is a major cause of 
blindness in the elderly. Unfortunately, no proven form of treatment 
is currently available for the dry, atrophic form of ARMD seen in 
more than 90% of patients with this condition. A recent theory 
suggests that ARMD is associated with damage to the retina caused 
by free radicals. If this is correct, it is possible that the damage 
could be prevented or moderated by supplementing the diet with 
specific antioxidant vitamins and minerals that enhance the body's 
natural defenses against free radicals. This paper reviews the 
literature regarding the pathogenesis of ARMD and presents a 
rationale for its management or prevention by the use of 
supplemental vitamins and minerals. 
Key Words 
Age-related macular degeneration, vision, vitamins, minerals, 
nutrition, free radicals, vitamin E, vitamin C, beta-carotene, zinc, 
selenium, copper, antioxidant supplements. 
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In the United States, age-related macular degeneration (ARMD) 
is the leading cause of blindness for persons over 60 years of age. 
ARMO exists in two forms: dry and wet. The dry form is 
characterized by a gradual reduction in central acuity and the 
presence of drusen. It can progress to the wet form, seen in about 
10% of ARMD patients, that is characterized by a rapid reduction in 
central acuity, choroidal neovascularization, and possible vessel 
leakage. Wet ARMD is potentially treatable by laser 
photocoagulation of the choroidal neovascularization, but there is 
currently no proven form of treatment for dry ARMD. 
In recent years, several interesting new theories regarding the 
pathophysiology of ARMD have been developed. In brief, these 
theories suggest that light (and other factors) cause the production 
of free radicals in the outer segments of the photoreceptors. These 
free radicals are either toxic themselves, or they can cause the 
production of toxic substances that are shed into the pigment 
epithelial (PE) cells during the normal sloughing of receptor outer 
segment components. These toxic products accumulate in the PE 
cells and are eventually excreted in the form of drusen. As drusen 
accumulate between the PE cells and the choriocapillaris, they block 
the exchange of metabolic materials, and the PE cells can no longer 
function. Without metabolic support from the PE cells, the 
receptors loose their ability to function and may die. 
Two important approaches to preventing or managing ARMD are 
suggested by this theory. First, it is possible that free radical 
production can be reduced by shielding the receptors from blue and 
ultraviolet (UV) light. Light with these wavelengths has a high 
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amount of energy per quanta, and these high energy quanta are 
thought to be associated with the production of free radicals. 
The second approach to ARMD prevention or management 
involves bolstering the body's natural defenses against free radical 
damage. These defenses make use of substances that can quench the 
free radicals without themselves becoming toxic; examples include 
vitamins such as C and E, along with enzymes that require minerals 
such as zinc and selenium for their production. The ability of these 
compounds and enzymes to quench free radicals suggests that 
dietary vitamin and mineral supplements might be ·useful for 
patients with ARMD or who are at risk for developing the disease. 
In this paper, the pathophysiology of ARMD will be reviewed, 
and a rationale for the use of vitamin and mineral supplementation 
will be presented. 
Free Radicals 
Free radicals are molecules that are missing an electron in 
their outer orbits; this makes them intrinsically unstable and highly 
reactive.1 To convert to stable state, a free radical must take an 
electron from another molecule, and in most cases, this converts the 
molecule from which the electron was taken to a free radical. The 
sequential stealing of electrons by free radicals often induces a 
cascade of biochemical chain reactions that can leave many 
molecules permanently altered or damaged. 
In the body, free radicals are produced naturally in many 
cellular structures including the mitochondria, lysosomes, 
endoplasmic reticulum, peroxisomes, and plasma membranes. In 
addition, various external sources, including light, ionizing 
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radiation, air pollutants, organic solvents, and cigarette smoke can 
produce free radicals within the body.2, 3 
Of the many types of free radicals, the most damaging are 
those derived from oxygen. (Table 1) 1 For example, a superoxide 
radical can be produced by the addition of an electron to molecular 
oxygen, and two superoxide radicals can combine with hydrogen to 
produce hydrogen peroxide. With the addition of an electron to 
hydrogen peroxide, the highly reactive hydroxyl radical is formed. 
Then, by acquiring another electron, the hydroxyl radical can be 
converted to water. Although the water that is the end-product of 
this chain is not harmful to the body, at several points in the chain 
electrons must be taken from other molecules. This loss of 
electrons can damage the molecules from which electrons are taken. 
Although not technically a free radical, singlet oxygen can also 
cause similar damage in the body. Singlet oxygen is produced when 
molecular oxygen absorbs energy causing the spin of one of the 
electrons to invert. Singlet oxygen is unstable and can damage 
molecules as it converts back to normal oxygen. In this way it 
behaves like a free radical, so it is often grouped together with free 
radicals in terms of its ability to damage the body.1 
------ -- ------------------------------------ ----~-------··-~· 
Insert Table 1 About Here 
Free Radical Damage in the Body 
Prime targets for free radical damage are the polyunsaturated 
fatty acids located in cell membranes. This is because the high 
number of double bonds found in these acids makes their molecules 
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especially easy to attack. The double bonds are convenient sources 
of electrons for free radicals to steal, but, as the free radicals 
quench themselves with electrons from the double bonds, the 
polyunsaturated fatty acid molecules become lipid peroxyl radicals. 
These lipid peroxyl radicals can be neutralized by stealing electrons 
from other polyunsaturated fatty acid molecules, however this 
creates more lipid peroxyl radicals. The reaction can cascade, 
consuming valuable polyunsaturated fatty acids and producing 
damaged molecules until all of the lipid peroxyl radicals are 
neutralized or are quenched by combining with antioxidants. 
Antioxidants are part of the body's natural defense against free 
radicals and are capable of quenching the free radicals without 
themselves becoming free radicals. 
In addition to damaging polyunsaturated fatty acids, free 
radicals can cause cell damage by denaturing sulfur-containing 
enzymes and other proteins, and they can damage DNA causing 
carcinogenic mutagens. For this reason, several theories have linked 
free radicals with the development of some forms of cancer in 
humans. 4,5 It has also been proposed that free radical damage is 
involved in atherosclerosis, heart disease, and cerebrovascular 
accidents.6 
Protection Against Free Radicals 
Because free radicals can have such a devastating effect on 
the body, several systems have evolved to provide protection against 
them. These include the use of antioxidant compounds such as 
vitamins C and E, beta-carotene, and enzymes such as superoxide 
dismutase, catalase, and glutathione peroxidase. (Table 2) 
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Insert Table 2 About Here. 
Vitamin C is a water-soluble antioxidant that is capable of 
quenching superoxide, hydroxyl radicals, and singlet oxygen. Vitamin 
E is a lipid-soluble antioxidant found in cell membranes; it is 
capable of quenching singlet oxygen, superoxide, and the lipid 
peroxyl radical. In cell membranes, it can terminate free radical 
induced chain reactions involving the unsaturated fatty acids. 
Beta-carotene is an orange pigment produced by many plants. 
It is lipid-soluble and found in the cell membranes of animals where 
it is an efficient quencher of singlet oxygen and free radicals. 7 
Chemically, beta-carotene is a pro-form of vitamin A and can serve 
as a dietary source for this vitamin. However, even though beta-
carotene is an effective antioxidant, vitamin A itself does not share 
this property.B 
Enzymes in the body's free radical defense system are also 
capable of converting free radicals to stable compounds before they 
can inflict major damage on the cell membranes. For example, 
superoxide dismutase (SOD) is an antioxidant enzyme that catalyzes 
the conversion of superoxide radicals to oxygen and hydrogen 
peroxide. For SOD to function properly, zinc, copper, and manganese 
mineral cofactors are required in the proper amounts. 
After SOD has converted superoxide radicals to oxygen and 
hydrogen peroxide, glutathione peroxidase (which requires the 
availability of selenium) and catalase (which requires the 
availability of zinc and copper) continue the process of detoxifying 
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the free radicals by converting the hydrogen peroxide to water and 
molecular oxygen. Glutathione peroxidase is also capable of 
converting the lipid peroxyl radicals formed in cell membranes to 
normal lipids; thus, it can stop the membrane damage caused by 
these free radicals. 
In the body, the extent of tissue damage caused by free 
radicals is determined by the balance between the quantity of free 
radicals that are generated and the strength of the antioxidant 
defense system. A variety of conditions can affect this balance. For 
example, environmental factors such as tobacco smoke, or the use of 
drugs (e.g., acetaminophen) can generate large quantities of free 
radicals. The balance can also be affected by poor nutrition that 
leads to deficiencies in the antioxidant vitamins and/or in the 
mineral cofactors used by the protective enzymes. In cases of this 
type, supplemention with vitamins and minerals can potentially be 
of great value. 
Generation of Free Radicals in the Retina 
Free radicals are produced in many parts of the body. In the 
retina, it is likely that they are produced as a result of light 
absorption by photopigments and/or other materials in the outer 
segments of the photoreceptors. uy and visible blue quanta seem 
especially capable of producing free radicals because of the 
relatively high energies these quanta carry. (Figure 1) 
• • • • ~ _ _ - - - • • • • - • • • - • • • - • - • • • • • - - • • • • • - • • • - • a • • • • • w w w ~ ~ ,. - • - • 
Insert Figure 1 About Here 
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Several studies have shown a relationship between the amount 
of short wavelength light to which a person is exposed and the 
occurrence of conditions like cataracts and ARMD that seem to be 
associated with free radicals.8,9, 10 For example, a strong 
association between exposure to blue light over a 20-year period and 
the incidence of ARMD was found in a study of Chesapeake Bay 
watermen.11 In this study it was further suggested that the normal 
mechanisms used by the retina to protect itself from free radicals 
produced by the short wavelength light might deteriorate with 
increasing age of the patient. This would upset the balance between 
free radical generation and quenching by antioxidants, and could 
result in the development of ARMD. 
The composition and structure of the photoreceptor outer 
segments make them especially vulnerable to free radical attack. 
The outer segments contain stacks of membranous discs that are 
rich in polyunsaturated fatty acids. When the photopigment 
molecules embedded in these disc membranes absorb quanta, they 
undergo a conformational change which starts the process of 
phototransduction. It is possible, however, that not all of the energy 
carried by the quantum is required to trigger the conformational 
change. The left-over energy is then available to produce free 
radicals, such as superoxides, that can damage the unsaturated fatty 
acids of the photoreceptor membranes. 
One of the techniques that receptors use to rid themselves of 
damaged membrane discs involves regenerating new discs at one end 
of the outer segment and sloughing packets of older discs into the 
pigment epithelial cells at the other end.12, 13 In the PE cells, the 
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phagocytized discs are digested by lysosomal enzymes into 
recyclable compounds. However, when free radicals have oxidized 
the unsaturated bonds of the fatty acids in the disc membranes and 
damaged the molecules, they cannot easily be digested. This is 
because the damaged molecules do not match the specific digestive 
enzymes available in the PE cells. As a result, th.e residues of the 
damaged molecules build up within the PE cells as lipofuscin 
granules. When a sufficient amount of this material has 
accumulated, it is deposited onto Bruch's membrane in the form of a 
drusen; drusen are one of the earliest and most easily detectable 
signs of ARMD. 
As the lipofuscin and drusen increase, they cause physical and 
metabolic disruption of the PE cells. In part, this is due to the fact 
that the drusen physically separate the PE cells from their blood 
supply in the choroid. (Figure 2) Since the photoreceptors receive 
their metabolic support from the PE cells, damage to the PE cells 
ultimately results in damage to photoreceptors as well . The end 
result of this process is ARMD. 
Insert Figure 2 About Here 
--- -- w ~ - ------------------------------- --- - --------- - .-------
Strategies for Possible Prevention and Management of ARMD 
The theory that links short wavelength light to the production 
of free radicals in the retina, and · to the inability of the PE cells to 
totally digest the discs phagocytized by them, suggests that ARMD 
could be prevented or managed in some patients. Two general 
strategies seem reasonable. First, if the retina could be shielded 
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from high energy quanta, fewer free radicals would be produced and 
the available antioxidants in the receptors could quench more of 
them before extensive damage was done. Second, the ability to 
quench free radicals could be enhanced by increasing the antioxidant 
levels in the retina via the use of dietary supplementation. 
Following the first approach, all ophthalmic lenses should have 
a significant ability to absorb UV light. The currently used plastic 
ophthalmic lens materials are reasonably good UV absorbers, and 
coatings can be added to glass lenses to increase their ability to 
absorb UV. In addition, the practice of implanting only UV absorbing 
intraocular lenses should be continued. UV absorbing ophthalmic 
lenses could be especially valuable for the elderly who have a 
reduced ability to quench free radicals. They should also probably be 
recommended for patients exposed to high UV levels. For normal 
adults, however, under typical conditions most of the incident UV 
light is absorbed by the cornea and lens, and therefore does not 
reach the retina. 
Unfortunately, even though the lens and cornea absorb UV 
reasonably well, they transmit visible blue light which has also been 
shown to damage the retina.11 For this reason, it seems prudent to 
suggest sunglasses that absorb most or all of the visible blue for 
patients who are exposed to high light levels (e.g., skiers, boaters, 
etc.), and/or for those who have signs or symptoms of ARMD.1 4 
The second approach to preventing or managing ARMD involves 
enhancing the body's free radical defenses.14 This can be done by 
increasing systemic levels of the antioxidant vitamins C and E, 
beta-carotene, and the trace minerals zinc, copper, manganese, and 
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selenium that are used by the metalloenzymes that quench free 
radicals. The human body does not produce these antioxidant 
vitamins and minerals internally, so it must have a continuous 
supply of them from either foods in the diet or from supplements. 
The dietary intake of these vitamins and minerals can directly 
affect their circulating levels and the activities of the antioxidant 
metalloenzymes.15, 16 
Use of Antioxidants to Protect the Retina 
A variety of studies have demonstrated that the level of 
antioxidant vitamins and metalloenzymes found in the eye are 
important in protecting the retina from light damage. For example, 
rats that were supplemented with vitamin C and exposed to intense 
light showed less photoreceptor damage than did rats who were not 
supplemented.17 The preservation of docosahexaenoic acid in the 
receptors (the main outer segment fatty acid in rods) suggests that 
vitamin C acts by inhibiting free radical oxidation of membrane 
lipids. Vitamin C treatment has also been shown to reduce the 
number of phagosomes present in the PE cells after light exposure. 
This suggests that vitamin C interrupts the formation of damaged 
photoreceptor components, probably by its ability to quench free 
radicals.1 8 
Studies with vitamin E and with beta-carotene suggest that 
these compounds also have antioxidant properties in the retina. 
Monkeys placed on vitamin E deficient diets developed a macular 
degeneration characterized by focal disruption of the photoreceptor 
outer segments, 19 and rats fed a vitamin E poor diet accumulated 
more lipofuscin in their PE cells than did animals on diets with 
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adequate vitamin E levels.20 Hess, et al., also found a decrease in 
retinal light damage in young rats when they were given 
supplements of vitamin E or beta-carotene.21 In humans, the 
consumption of fruits and vegetables that are inherently rich in 
beta-carotene has been shown to have an inverse correlation with 
the incidence of ARMo.22 
Antioxidant metalloenzymes also play an important role in 
protecting the retina from light damage. For example, a high 
concentration of selenium that is used by the enzyme glutathione 
peroxidase is found in PE cells.23 This enzyme has significant 
antioxidant properties, and reduced activity levels have been 
associated with the development of ARMD in humans.24 
Another antioxidant metalloenzyme, catalase, uses zinc as a 
cofactor, and the enzyme has been found to be more active in the PE 
cells than in any other ocular tissues. The enzyme is especially 
interesting because its activity decreases during the sixth to ninth 
decades of human life when lipofuscin accumulation in the PE cells 
and ARMD frequency increase.25 In addition, it has been found that 
the decrease in catalase activity is more pronounced in older 
patients with ARMo.25 
In addition to being a component of the antioxidant enzymes 
catalase and superoxide dismutase, zinc is also a cofactor for the 
lysosomal enzyme alpha-mannosidase that is found in PE cells. The 
activity of this enzyme decreases with age, but supplemental zinc 
can significantly reactivate it.26 It has been proposed that 
lipofuscin accumulates in the PE cells as a result of inefficient or 
insufficient lysosomal enzymes, and this results in the formation of 
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drusen. If this is correct, and if zinc can reactivate the enzyme, a 
strong case can be made for zinc supplementation in patients who 
have ARMD or who are at risk for developing it. 
Supplementation with Antioxidants 
The literature describing free radical effects on the visual 
system suggests that it would be prudent for all patients, especially 
those over 50, to maintain high levels of antioxidant vitamins and 
minerals. Unfortunately, nutritional surveys in the United States 
have found that many older people do not have adequate dietary 
intakes of these substances.27 It is possible that these 
deficiencies might increase their risk of developing a free radical-
based disease such as ARMD, but it is very hard to change the 
lifelong dietary habits of people, especially the elderly. For this 
reason, supplementation with antioxidant vitamins and minerals 
might be desirable for these patients in order to maintain their 
antioxidant defenses at optimum levels. 
Newsome, et al., investigated the value of antioxidant 
supplementation specifically for ARMD patients.28 They gave ARMD 
patients supplemental oral zinc sulfate over a two-year period and 
found that the supplemented patients had significantly less vision 
loss than did controls. Objective evaluations of the patients' 
macular photographs taken before and after supplementation showed 
that the zinc treated group either remained stable or had less of an 
increase in visible drusen than did the control group. 
The work by Newsome and others has inspired a number of 
additional studies designed to investigate the use of antioxidant 
supplementation. Many of these studies are in progress or are just 
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about to get underway, so it will be several years before they can 
provide definitive data on the relationship between ARMD and 
supplementation. 
In one just completed study, 192 ARMD patients were given 
antioxidant supplements and 61 control subjects were untreated. 
After 6 months, 87.5% of the supplemented patients versus 59% of 
the controls had visual acuities equal to or better than baseline (i.e., 
showed no deterioration in acuity).a Another study, currently 
underway at eight centers, is designed to evaluate the ability of 
individual antioxidant vitamins and minerals to retard the 
progression of ARMD and cataracts. Preliminary results suggest 
that the antioxidants have value for this purpose.a 
A multi-center study now being conducted at several Veterans 
Administration and College of Optometry clinics will also provide 
information on the relationship between ARMD and antioxidants. In 
this study, 160 subjects with ARMD will be divided into two groups; 
one group will receive antioxidant supplements and the other group 
will receive placebos. Changes in retinal function and appearance 
will be evaluated over the two-year period of the study.b 
Still another study, called the Age-Related Eye Disease Study, 
is also just getting underway. This 1 0-year study, sponsored by the 
National Eye Institute, will use 4600 subjects to investigate the 
predisposing and prognostic factors, as well as clinical courses of 
patients with ARMD and cataracts. It is quite possible that this 
study will provide additional theoretical support for the use of 
antioxidants in the treatment or prevention of ARMD and/or 
cataracts. c 
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The results of these studies will no doubt clarify the 
relationship between conditions like ARMD and the need for 
antioxidant vitamin and mineral supplements, but their results will 
not be available for several years. What is the appropriate course of 
action for a patient who now has ARMD or who is showing signs of 
developing ARMD? Is it possible that supplementation might be 
appropriate for these patients based on the possibility that the 
antioxidants could affect the progression of the disease? 
Over-The-Counter Antioxidant Supplements 
Even though it is not yet definite that antioxidants can help 
patients with eye problems, several manufacturers have introduced 
products that are directed toward eye health. These products 
include: ICAPS-Pius® (La Haye Laboratories, 2205 152nd Avenue NE, 
Redmond, WA 98052, 800 344-2020), NutriVision™ (Bronson 
Pharmaceuticals, 4526 Rinetti Lane, P.O. Box 628, LaCanada, CA 
91012-0628, 800 235-3200), Ocuguard® (Eye Care Communications 
Inc., 1241 W. Ninth Street, Upland, CA 91786, 800 247-5731 ), 
Ocuvite® (Storz Ophthalmics Inc., 3365 Tree Court Ind. Blvd., St. 
Louis, MO 63112, 800 325-9929), OCuSOFT® VMS (Ocusoft Inc., P.O. 
Box 429, Richmond, TX 77406-0429, 800 223-4569), and Spectra-
Antioxidants™ (Spectrum Scientific Pharmaceuticals Inc., P.O. Box 
2469, Covington, LA 70434, 800 228-2654). The formulations of 
these products are shown in Table 3. The recommended daily 
allowances (RDAs) and toxic levels for the vitamins and minerals in 
the products are also shown for comparison purposes. Comparisons 
are somewhat difficult, however, because the instructions with 
several of the products are vague about daily doses. 
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Insert Table 3 about here. 
Because the use of supplements to protect against free radical 
diseases in the eye is still relatively new, the optimum dosages of 
each of the vitamins and minerals is unknown. It is interesting to 
note that although all products list vitamin A among their 
ingredients, not all of them actually contain vitamin A. Vitamin A is 
an essential nutrient in the body, but it does not have significant 
antioxidant properties. Instead of vitamin A, most products 
probably contain beta-carotene. This substance is called a pro-form 
of vitamin A because it can be converted to vitamin A in the 
intestine, but more importantly, beta-carotene itself is a potent 
antioxidant. This is why it is included in the supplements. It is also 
interesting to note that the products contain different amounts and 
forms of zinc, and that not all of the products contain the same 
substances. Do these differences make one product better than the 
others? Possibly, but information from additional studies will be 
needed before this question can be answered definitively. 
Conclusion 
The theory relating free radical damage to the etiology of 
ARMD seems sound. The explanations of how antioxidants found 
naturally in the body or introduced through supplements can mitigate 
the damage caused by the free radicals also seem sound. Beyond 
this, the work of Newsome, et al., strongly suggests that for some 
patients with ARMD the use of zinc can be beneficial. Unfortunately, 
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the studies needed to more completely define the benefits of 
antioxidants for the management and/or prevention of free radical 
diseases like ARMD have not been completed, so it will be several 
years .before the evidence showing the efficacy of antioxidants will 
be available. 
In the meantime, is it appropriate to recommend 
supplementation to all patients, to those with drusen, to those with 
exposure to high light levels, or to no patients? The answers to 
these questions probably require a cost/risk/benefit analysis of the 
supplements. With respect to cost, retail price of the supplements 
is about 25 cents per day; with respect to risk, the quantities of 
vitamins and minerals in the products are well below the toxic 
levels shown on Table 3, and it is unlikely that toxic levels would be 
reached if the products are taken as supplements to a normal diet. 
This leaves the question of benefit. Do the products provide benefits 
to patients equal to their cost? This is a question each doctor must 
answer for each individual patient, but at this time it appears 
reasonable to suggest supplementation to most or all patients 
pending completion of the studies that will provide definitive 
information on efficacy. 
18 
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Figure Captions 
Figure 1. This figure schematically illustrates how free radicals 
produced by light can either be quenched by antioxidants or can 
produce the damage associated with ARMD. 
Figure 2. Drusen can separate the PE cells from their blood supply, 
and this can result in the death of photoreceptors. 
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Table 1. Active Oxygen Species 
Formula Name 
o2- Superoxide radical 
H02. Hydroperoxyl radical 
H202 Hydrogen peroxide 
OH' Hydroxyl radical 
ROO' Lipid peroxyl radical 
1o2 Singlet Oxygen 
denotes a free electron 
1 denotes an inverted spin on one 
electron 
24 
Table 2. Antioxidant defense mechanisms 
Mechanism 
Antioxidant Compounds 
Vitamin C 
Vitamin E 
Beta -carotene 
Antioxidant Enzymes 
Superoxide dismutase 
Requires zinc, copper, and 
manganese for activity 
Catalase 
Requires zinc and copper 
for activity 
Glutathione peroxidase 
Requires selenium 
for activity 
Activity 
Water-soluble; quenches free 
radicals to prevent lipid 
peroxidation, regenerates 
vitamin E 
Membrane-bound, lipid-soluble; 
quenches free radicals to 
prevent lipid peroxidation and to 
terminate chain reactions in 
membranes 
Membrane-bound, lipid-soluble; 
quenches free radicals to 
prevent lipid peroxidation and to 
terminate chain reactions in 
membranes 
Converts superoxide radical to 
hydrogen peroxide 
Converts hydrogen peroxide to 
water and molecular oxygen 
Converts hydrogen peroxide to 
water and molecular oxygen; 
reduces lipid peroxyl radicals to 
normal lipids 
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Table 3. Ingredients of several products currently on the market as 
compared with RDA and toxic levels of these ingredients. Each 
ingredient is amount per tablet or capsule. 
Micro- Ocuvite® I CAPS- Ocuguard® Nutri- OCuSOFT® Spectre- Toxic 
nutrient Plus® Vision™ VMS Anti- Levels* 
(RDA) oxidants™ 
Vitamin C 60 mg 200 mg 375 mg 300 mg 60 mg 400 mg Prolonged 
(60 mg) intake 
exceeding 
1 g/day 
Vitamin E 30 IU 60 IU 100 IU 100 IU 30 IU 200 IU Greater 
(30 IU) than 
800 IU 
daily 
Beta- 5000 IU 6000 IU 10000 IU 5000 IU 5000 IU 5000 IU Greater 
Carotene than 
(NE) 150,000 
IU daily 
Zinc 40 mg 30 mg 6.25 30 mg 40 mg 40 mg Prolonged 
(15 mg) intake 
of 150 mg 
daily 
Copper 2 mg 1.5 mg none 1.5 mg 2 mg 2 mg Greater 
(2 mg) than 
20 mg 
daily 
Mang- none 5 mg none none none none Greater 
anese than 
(NE) 8-9 mg 
daily 
Selenium 40 meg 30 meg 25 meg 50 meg 40 meg 40 meg Maximum 
(NE) daily 
intake is 
500 meg 
Riboflavin none 20 mg 12.5 mg none none none No known 
(1 .7 mg) toxic 
level 
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Table 3. Continued 
Other none none Bioflave- Chromium none Gluta-
lngred- no ids, thione, 
ients Taurine, Pyruvate 
N-acetyl 
cysteine, 
Glutathi-
one, 
Chromium 
Dose 1 or 2 1 or 2 4 daily 1 or 2 1 or 2 1 or 2 
daily daily daily daily daily 
* Shils ME, Young VA, eds. Modern Nutrition in Health and Disease, 
7th ed. Philadelphia: Lea & Febiger, 1988. 
NE = None Established 
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